Avanos Medical Inc. (NYSE: AVNS) entered into a definitive agreement to be acquired by affiliates of American Industrial Partners (AIP) in an all‑cash transaction valuing the company at an enterprise value of approximately $1.272 billion. Shareholders will receive $25.00 per share, a premium of 72.1% to the April 13, 2026 closing price and 82.8% to the 30‑day volume‑weighted average price for the period ending April 13.
Continue reading for full analysis...